October 2026Association of serum sodium and outcomes in patients receiving checkpoint inhibition for metastatic NSCLCPublication summaryPublicationsNon-small cell lung cancer
October 2026Leveraging large language models to characterize serious illness conversations in advanced non-small cell lung cancerPublication summaryPublicationsMachine learningNon-small cell lung cancerArtificial intelligence
October 2026Quality of care in US community oncology practices among patients with metastatic breast cancer and metastatic non-small cell lung cancerPublication summaryPublicationsBreast cancerNon-small cell lung cancerCommunity oncology
August 2026Real-world treatment duration and outcomes among patients with early-stage NSCLC receiving adjuvant osimertinib: a retrospective cohort studyPublication summaryPublicationsNon-small cell lung cancer
August 2026Genomic alterations without approved 1L targeted therapies in patients with NSCLC PD-L1 ≥50% treated with immunotherapyPublication summaryPublicationsNon-small cell lung cancerMolecular data
August 2026Real-world outcomes with chemoradiation and durvalumab consolidation in stage III KRAS G12C-mutant NSCLC in the USPublication summaryPublicationsNon-small cell lung cancer
August 2026Beyond the clinical trial: real-world treatment patterns and drivers of PD-(L)1 therapy use in first-line metastatic NSCLCPublication summaryPublicationsNon-small cell lung cancer